Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Omega Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 18.1K | Jun 7, 2023 | Direct | ||
Protara Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 10K | Jun 7, 2024 | Direct | ||
REGENXBIO Inc. | Director | Stock Option (Right to Buy) | 10K | Jun 4, 2021 | Direct | ||
Trillium Therapeutics Inc. | Director | Deferred Share Unit | 0 | Nov 17, 2021 | Direct | ||
Trillium Therapeutics Inc. | Director | Stock Option (Right to Buy) | 0 | Nov 17, 2021 | Direct |